>
Potent,selectiveandcompetitivenon-peptideendothelinETAreceptorantagonist(Ki=48nM).Displays>1000-foldselectivityoverETBreceptors.InhibitsET-1-inducedpressorresponsefollowingoralorintravenousadministrationinvivo.InhibitsET-1-inducedlongitudinalmusclecontractioninthemousecoloninvitro.
SoldwiththepermissionofBristol-MyersSquibbCompany,subjecttoU.S.PatentNo.5,378,715andotherUSandforeignpatents
BMS182874hydrochlorideisalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight381.88.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.